Current Studies

Study Details

Respiratory Syncytial Virus (RSV) Vaccine

Study Information

Help us advance RSV vaccine research in older adults.

Respiratory Syncytial Virus (RSV) is a leading cause of serious respiratory tract disease in older adults.

The Respiratory Syncytial Virus (RSV) is a highly contagious virus that impacts everyone and in mild cases presents like a common cold. However, RSV can cause more serious respiratory illness, mainly in older adults and in young infants. Similar to influenza (flu), RSV season is common during the winter months, in temperate climates. RSV and flu are different viruses. Therefore, you can still get an RSV
infection even if you have been vaccinated against the flu.

There is currently no licensed RSV vaccine, but we are now enrolling older adults in a clinical trial to evaluate an investigational RSV vaccine.

If you are at least 60 years of age and are interested in participating in the AReSVi 004 study, please fill out the form below.

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

  • Study Information

  • Contact Information

  • Please enter a number from 18 to 99.